Intrinsiqs

Is Bristol-Myers Squibb Company overvalued?

Bristol-Myers Squibb Company (BMY) looks undervalued — trading about 22% below its fair value.

Undervalued
Current price $57.52 Fair value $70.12
Price
$57.52
Fair value
$70.12
Current P/E
16.7
Normal P/E
20.3
Market cap
$117.46B
Dividend yield
4.6%
Return on equity
38.2%
Sector
Healthcare

See the full interactive analysis →

Fair value compares BMY's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 28 Jun 2026.

Related stocks

LLY Eli Lilly and CompanyJNJ Johnson & JohnsonABBV AbbVie Inc.UNH UnitedHealth Group IncorporatedMRK Merck & Co., Inc.AMGN Amgen Inc.